| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.700 | None | 0.980 | 251 | 43 | 1993 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 5 | 0.513 | 0.654 | 0.91 |
|
disease | 0.700 | strong | 0.987 | 146 | 29 | 1995 | 2020 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 1 | 0.588 | 0.615 | 3.4E-03 |
|
disease | 0.700 | None | 0.983 | 44 | 6 | 1997 | 2018 | ||||||||
|
potassium voltage-gated channel subfamily H member 2 | 0.522 | 0.731 | 1.00 |
|
disease | 0.500 | None | 0.990 | 204 | 42 | 1995 | 2020 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 2 | 0.628 | 0.423 | 1.0E-04 |
|
disease | 0.400 | None | 1.000 | 33 | 1 | 1998 | 2016 | ||||||||
|
ryanodine receptor 2 | 0.539 | 0.615 | 1.00 |
|
disease | 0.400 | None | 1.000 | 11 | 0 | 2005 | 2018 | ||||||||
|
sodium voltage-gated channel beta subunit 4 | 0.705 | 0.346 | 6.5E-07 |
|
disease | 0.320 | limited | 1.000 | 1 | 0 | 2007 | 2014 | ||||||||
|
potassium voltage-gated channel subfamily E regulatory subunit 3 | 0.666 | 0.423 | 0.47 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.200 | None | 0.962 | 11 | 7 | 2004 | 2019 | ||||||||
|
caveolin 3 | 0.564 | 0.692 | 5.5E-03 |
|
disease | 0.190 | None | 0.964 | 9 | 2 | 2000 | 2019 | ||||||||
|
ankyrin 2 | 0.626 | 0.538 | 1.00 |
|
disease | 0.170 | None | 1.000 | 6 | 1 | 2005 | 2019 | ||||||||
|
syntrophin alpha 1 | 0.678 | 0.308 | 5.6E-03 |
|
disease | 0.160 | None | 1.000 | 6 | 1 | 2008 | 2019 | ||||||||
|
myosin binding protein C3 | 0.593 | 0.385 | 8.0E-11 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2007 | 2014 | ||||||||
|
KCNQ1 opposite strand/antisense transcript 1 | 0.534 | 0.731 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 1997 | 2018 | |||||||||
|
A-kinase anchoring protein 9 | 0.638 | 0.385 | 4.5E-17 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 2 | 0.572 | 0.731 | 0.31 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2003 | 2017 | ||||||||
|
calmodulin 2 | 0.472 | 0.808 | 0.92 |
|
disease | 0.060 | None | 1.000 | 6 | 2 | 2016 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1991 | 1994 | ||||||||
|
calmodulin 1 | 0.472 | 0.808 | 0.94 |
|
disease | 0.050 | None | 1.000 | 5 | 4 | 2016 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily A member 5 | 0.606 | 0.500 | 1.1E-03 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1997 | 2007 | ||||||||
|
nitric oxide synthase 1 adaptor protein | 0.608 | 0.423 | 0.61 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 2009 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily A member 4 | 0.716 | 0.423 | 0.98 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1997 | 2007 | ||||||||
|
calmodulin 3 | 0.485 | 0.846 | 0.93 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2016 | 2019 | ||||||||
|
potassium two pore domain channel subfamily K member 3 | 0.584 | 0.654 | 0.90 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1997 | 2007 | ||||||||
|
potassium voltage-gated channel subfamily D member 3 | 0.619 | 0.615 | 0.99 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2000 | 2008 |